Trial intelligence / Profile preview

Effect of mirtazapine in treatment of migraine

IRCT20260430069215N1Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of mirtazapine in migraine, sponsored by Arak University of Medical Sciences. Started Jun 2026; status: completed.

02

Drugs

mirtazapine
03

Conditions

migraine

Beyond the preview

Go deeper on IRCT20260430069215N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20260430069215N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call